| Literature DB >> 17143963 |
Abstract
Rituximab has been associated with the development of cytomegalovirus enterocolitis in immunosuppressed patients. A 51-year-old patient with diffuse large B-cell lymphoma who received a conditioning chemotherapy regimen (RCVP and RICE) consisting of rituximab before bone marrow transplantation went on to develop cytomegalovirus enterocolitis. This supports evidence from previously described cases that rituximab may be associated with cytomegalovirus enterocolitis.Entities:
Mesh：
Substances：
Year: 2006 PMID： 17143963 PMCID： PMC4087505 DOI： 10.3748/wjg.v12.i45.7391
Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742